Over the last five years, there has been an unprecedented surge in demand for biotherapeutics and biomanufacturing to help treat life-altering diseases, such as cancer, cardiovascular disease, neurological disease and other conditions. To help respond to this demand, the University of Ottawa is partnering with the Ottawa Hospital’s Biotherapeutics Manufacturing Centre (BMC) to manufacture much-needed biotherapeutics – essential tools for innovative treatments that not only improve quality of life for patients, but also save lives.
By advancing ground-breaking research in biomanufacturing, while also providing critical training and skills development opportunities for students in the field, the BMC is helping bolster Ontario’s life sciences sector. In addition, the centre contributes to the Canadian Pandemic Preparedness Hub (CP2H) to help future-proof the country against further shocks to the health-care and life sciences systems.
For more information, visit University of Ottawa.
